Merck's faster acting and more potent formulation relieves headache pain better than ibuprofen March 23, 1999
Calpain I inhibitors designed at Cephalon show neuroprotective activity in animal model March 23, 1999
New formulation of buspirone shows improved pharmacokinetics, not affected by hepatic impairment March 23, 1999
AMPA receptor antagonists claimed for epilepsy, muscle spasms and neurodegenerative disorders March 23, 1999
RSS